Entera Bio Ltd. — Director's Dealing 2025

Apr 30, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2025-04-28

Reporting Person: Galitzer Hillel (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-04-28	Ordinary Shares, par value NIS 0.0000769 per share	A	26316	—	Acquired	90573	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-28	Stock Option (right to buy)	$2.28	A	100000	Acquired	2025-04-28	Ordinary Shares, par value NIS 0.0000769 per share (100000)	Direct

Footnotes

F1: Represents a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 28, 2025.

F2: The options vest over a three-year period with 33% of the options vesting on April 28, 2025, the first anniversary of the vesting commencement date, and the remaining options vesting ratably on a quarterly basis over the remaining three-year period.